AGP Picks
View all

The Africa Gazette
Provided by AGP

The Africa Gazette: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Africa Gazette.

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

August 2026

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31

September 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30

Press releases published on August 31, 2026

Chloe Kim Teams Up with Qelbree®, the #1 Prescribed Branded Non-Stimulant ADHD Treatment*, to Help Empower People Navigating ADHD
Aug. 31, 2026

Chloe Kim Teams Up with Qelbree®, the #1 Prescribed Branded Non-Stimulant ADHD Treatment*, to Help Empower People Navigating ADHD

Indeterminate GlobeNewswire
AEON Biopharma to Participate in Lake Street Capital Markets’ 10th Annual Best Ideas Growth (BIG10) Conference
Aug. 31, 2026

AEON Biopharma to Participate in Lake Street Capital Markets’ 10th Annual Best Ideas Growth (BIG10) Conference

Indeterminate GlobeNewswire
Revelyx Bio Launches to Advance YY003, an Investigational Recombinant Botulinum Toxin Type A in a Ready-to-Use Liquid Formulation
Aug. 31, 2026

Revelyx Bio Launches to Advance YY003, an Investigational Recombinant Botulinum Toxin Type A in a Ready-to-Use Liquid Formulation

Indeterminate GlobeNewswire
ORYZON Announces Notice of Allowance for U.S. Patent Application Covering Iadademstat Combination With Gilteritinib
Aug. 31, 2026

ORYZON Announces Notice of Allowance for U.S. Patent Application Covering Iadademstat Combination With Gilteritinib

Indeterminate GlobeNewswire
CAP S.A. Announces Commencement of Cash Tender Offer and Consent Solicitation for Any and All of Its Outstanding 7.375% Notes Due 2036
Aug. 31, 2026

CAP S.A. Announces Commencement of Cash Tender Offer and Consent Solicitation for Any and All of Its Outstanding 7.375% Notes Due 2036

Indeterminate GlobeNewswire
Goliath Confirms Multiple Broad Intervals Of Gold Mineralization Connecting The Bonanza And Golden Gate Zones That Remain Open For Expansion, Drilling Continues On The High-Grade Gold Surebet Discovery, Golden Triangle, B.C.
Aug. 31, 2026

Goliath Confirms Multiple Broad Intervals Of Gold Mineralization Connecting The Bonanza And Golden Gate Zones That Remain Open For Expansion, Drilling Continues On The High-Grade Gold Surebet Discovery, Golden Triangle, B.C.

Indeterminate GlobeNewswire
Goldera Provides Update on 2026 Exploration Programs Targeting Multiple Gold Discovery Opportunities in Ontario and New Brunswick
Aug. 31, 2026

Goldera Provides Update on 2026 Exploration Programs Targeting Multiple Gold Discovery Opportunities in Ontario and New Brunswick

Indeterminate GlobeNewswire
Helium Evolution Announces DTC Eligibility Allowing for Electronic Settlement of Trades in the United States and Grant of Stock Options
Aug. 31, 2026

Helium Evolution Announces DTC Eligibility Allowing for Electronic Settlement of Trades in the United States and Grant of Stock Options

Indeterminate GlobeNewswire
Nova Minerals Attends Roundtable with U.S. Department of Energy
Aug. 31, 2026

Nova Minerals Attends Roundtable with U.S. Department of Energy

Indeterminate GlobeNewswire
MEXC Launches MEXC Global Card With Up to 10% Cashback and 7% Annualized Returns
Aug. 31, 2026

MEXC Launches MEXC Global Card With Up to 10% Cashback and 7% Annualized Returns

Indeterminate GlobeNewswire
XYRA Announces First Patient Dosed in Europe in the Phase 2/3 HARBOR-AF Study of Budiodarone in Paroxysmal and Persistent Atrial Fibrillation
Aug. 31, 2026

XYRA Announces First Patient Dosed in Europe in the Phase 2/3 HARBOR-AF Study of Budiodarone in Paroxysmal and Persistent Atrial Fibrillation

Indeterminate GlobeNewswire
HUTCHMED Announces SANOVO Trial Demonstrated Significant Progression-Free Survival Benefit of ORPATHYS® Plus TAGRISSO® in Treatment-Naïve Patients with MET-Overexpressing EGFR-mutated Lung Cancer in China
Aug. 31, 2026

HUTCHMED Announces SANOVO Trial Demonstrated Significant Progression-Free Survival Benefit of ORPATHYS® Plus TAGRISSO® in Treatment-Naïve Patients with MET-Overexpressing EGFR-mutated Lung Cancer in China

Indeterminate GlobeNewswire

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

The Africa Gazette

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.